Cambiar Investors LLC Zai Lab LTD Transaction History

Cambiar Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$125.11 - $180.0 $1.65 Million - $2.37 Million	-13,183 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $1.03 Million - $1.56 Million	-8,155 Reduced 38.22%	13,183 $1.76 Million
Q3 2020 Oct 21, 2020	SELL	$73.3 - $89.48 $524,608 - $640,408	-7,157 Reduced 25.12%	21,338 $1.78 Million
Q2 2020 Aug 03, 2020	BUY	$48.82 - $82.53 $411,113 - $694,985	8,421 Added 41.95%	28,495 $2.34 Million
Q1 2020 Apr 30, 2020	BUY	$39.1 - $62.9 $231,002 - $371,613	5,908 Added 41.71%	20,074 $1.03 Million
Q4 2019 Feb 06, 2020	BUY	$29.79 - $43.06 $1,846 - $2,669	62 Added 0.44%	14,166 $589,000
Q1 2019 May 08, 2019	SELL	$21.71 - $31.54 $158,700 - $230,557	-7,310 Reduced 34.14%	14,104 $416,000
Q3 2018 Oct 25, 2018	BUY	$17.8 - $25.35 $381,169 - $542,844	21,414 New	21,414 $417,000

146

53M

103K

439K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Cambiar Investors LLC with notifications on news.